22
QI’s CEO, Tom Kirk, was invited to represent Quantified Imaging at the launch of the next stage of the Barbara Windsor Dementia Mission at Downing Street. The next phase will advance research into dementia by linking up large datasets (Dementias Platform UK) and accelerating clinical trials. QI will play its role by developing non-contrast perfusion MRI as a scalable and cost-effective replacement for PET imaging, which just 2% of patients in the UK currently access.
